Valneva SE (0OB3)
LSE
Closed
Aug 25, 2026
Day's Range
2.8152 wk Range
2.03Overview - 0OB3 - Valneva SE
Key Statistics
Valuation
Enterprise Value
644.41M
P/E (Trailing)
‪0.92‬
Price / Sales (TTM)
‪0.0035‬
Price / Book
‪6.65‬
EV / EBITDA
‪-6.52‬
Profitability
Profit Margin
‪-110.29%‬
Operating Margin
‪-74.91%‬
Return on Assets
‪-16.68%‬
Return on Equity
‪-117.84%‬
Ownership
Shares Outstanding
76.50M
Float
157.26M
Held by Insiders
‪10.72%‬
Held by Institutions
‪24.41%‬
Price stats
Beta
‪1.34‬
50-Day Avg
‪3.76‬
200-Day Avg
‪5.41‬
Dividends
Frequency
Annual
Market Cap - 0OB3 - Valneva SE
Peers - 0OB3 - Valneva SE
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- 0OB3LSEValneva SE224.16MMarket Cap-33.09%52-week change0.95P/E (Trailing)‪-110.29%‬Profit Margin
- 0MGBLSEGenmab A/S168.24BMarket Cap+25.25%52-week change30.65P/E (Trailing)‪29.01%‬Profit Margin
- 0QZULSEVertex Pharmaceuticals Incorporated140.31BMarket Cap+29.11%52-week change0.58P/E (Trailing)‪34.99%‬Profit Margin
- 0R2MLSERegeneron Pharmaceuticals, Inc.90.49BMarket Cap+30.71%52-week change0.12P/E (Trailing)‪27.86%‬Profit Margin
- 0A45LSEModerna, Inc.66.31BMarket Cap+81.03%52-week change55.34P/E (Trailing)‪11.32%‬Profit Margin
- 0QW0LSEargenx SE52.61BMarket Cap+34.75%52-week change42.42P/E (Trailing)‪-47.51%‬Profit Margin
- 0NZTLSEUCB SA44.92BMarket Cap+9.88%52-week change127.93P/E (Trailing)‪6.45%‬Profit Margin
Profile Summary - 0OB3 - Valneva SE
About
Valneva SE is a specialty vaccine company headquartered in Saint-Herblain, France, that develops, manufactures, and commercializes prophylactic vaccines targeting infectious diseases with significant unmet medical needs. Its commercial portfolio features three key vaccines: IXIARO®, for Japanese encephalitis;…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
